Community Research and Development Information Service - CORDIS

FP6

Final Report - LCVAC (New vaccination therapies for lung cancer)

Project ID: 512855
Funded under: FP6-SME

Abstract

This is the final report for the LCVAC project, which received funding from the European Commission's Sixth Framework Programme (FP6). Its main aim was to identify and characterise novel lung cancer specific antigens, characterise human lung cancer cell lines, as well as develop an efficient and safe vaccination protocol.

In the beginning the report covers a brief overview including some background information about lung cancer and the current inadequate clinical tools for diagnostics and therapeutics, the ultimate aim and the principal objective of the project, the main areas of focus of research, as well as the main outcomes of the project and the dissemination activities.

The first part covers the project objectives and major achievements, the second covers the objectives and work performed of the five work packages (WPs) that the project consists of, and the third part refers to the consortium management activities. The report concludes with a fourth part which covers the dissemination activities.

Download application/zip (11139947)

Related information

Record Number: 12796 / Last updated on: 2011-04-14
Category: PROJ